Finance

Lists
1733:TPE
Apex Biotechnology Corp
NT$29.85
-0.83%
(-0.25) 1D
Oct 19, 1:30:25 PM GMT+8  ·   TWD
All symbols
SymbolPriceChange% Change
Generating top insights for 1733...
Open
NT$30.10
High
NT$30.20
Low
NT$29.70
Mkt. cap
2.98B
Avg. vol.
109.58K
Volume
79.54K
Dividend
4.36%
Quarterly dividend
NT$0.32
Ex-dividend date
Jun 9, 2026
P/E ratio
15.80
52-wk high
NT$38.70
52-wk low
NT$28.00
EPS
NT$1.89
Shares outstanding
99.69M
No. of employees
641
Open
NT$30.10
High
NT$30.20
Low
NT$29.70
Mkt. cap
2.98B
Avg. vol.
109.58K
Volume
79.54K
Dividend
4.36%
Quarterly dividend
NT$0.32
Ex-dividend date
Jun 9, 2026
P/E ratio
15.80
52-wk high
NT$38.70
52-wk low
NT$28.00
EPS
NT$1.89
Shares outstanding
99.69M
No. of employees
641
News stories
From web sources and news partners
About Apex Biotechnology Corp
CEO-
Employees641
Founded1997
Headquarters-
SectorMedical device
Websiteapexbio.com
Previous reportsAll values in TWD
Loading Previous Earnings...
Revenue
Net income
All values in TWD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
437.21M
438.99M
519.72M
470.65M
Cost of goods sold
330.39M
306.63M
344.06M
312.37M
Cost of revenue
330.39M
306.63M
344.06M
312.37M
Research and development expenses
35.94M
36.02M
37.23M
49.84M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
57.27M
62.79M
60.29M
63.81M
Operating expense
98.80M
99.12M
88.45M
113.66M
Total operating expenses
429.19M
405.75M
432.51M
426.02M
Operating income
8.02M
33.24M
87.21M
44.63M
Other non operating income
775.00K
894.00K
191.00K
591.00K
EBT including unusual items
29.21M
58.17M
86.91M
44.68M
EBT excluding unusual items
34.02M
57.52M
90.23M
41.45M
Income tax expense
7.12M
7.97M
5.54M
7.84M
Effective tax rate
24.37%
13.70%
6.38%
17.54%
Other operating expenses
-
-
-
-
Net income
22.14M
50.08M
81.28M
36.78M
Net profit margin
5.06%
11.41%
15.64%
7.81%
Earnings per share
-
-
-
-
Interest and investment income
139.00K
1.49M
219.00K
4.56M
Interest expense
-835.00K
-822.00K
-829.00K
-804.00K
Net interest expenses
-696.00K
665.00K
-610.00K
3.75M
Depreciation and amortization charges
-
-
-
-
EBITDA
20.24M
45.47M
99.16M
56.25M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps